Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.
Times cited: 20
Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: The role of checkpoint inhibition in the bone.
Journal for ImmunoTherapy of Cancer.
Times cited: 1
Immunologic correlates of the abscopal effect in a patient with melanoma.
New England Journal of Medicine.
Times cited: 1087